Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 406

1.

Thymosin β4 promotes autophagy and repair via HIF-1α stabilization in chronic granulomatous disease.

Renga G, Oikonomou V, Moretti S, Stincardini C, Bellet MM, Pariano M, Bartoli A, Brancorsini S, Mosci P, Finocchi A, Rossi P, Costantini C, Garaci E, Goldstein AL, Romani L.

Life Sci Alliance. 2019 Nov 12;2(6). pii: e201900432. doi: 10.26508/lsa.201900432. Print 2019 Dec.

PMID:
31719116
2.

Targeting the Aryl Hydrocarbon Receptor With Indole-3-Aldehyde Protects From Vulvovaginal Candidiasis via the IL-22-IL-18 Cross-Talk.

Borghi M, Pariano M, Solito V, Puccetti M, Bellet MM, Stincardini C, Renga G, Vacca C, Sellitto F, Mosci P, Brancorsini S, Romani L, Costantini C.

Front Immunol. 2019 Oct 11;10:2364. doi: 10.3389/fimmu.2019.02364. eCollection 2019.

3.

Invasive mould infections in solid organ transplant patients: modifiers and indicators of disease and treatment response.

Welte T, Len O, Muñoz P, Romani L, Lewis R, Perrella A.

Infection. 2019 Oct 1. doi: 10.1007/s15010-019-01360-z. [Epub ahead of print] Review.

PMID:
31576498
4.

A Reappraisal of Thymosin Alpha1 in Cancer Therapy.

Costantini C, Bellet MM, Pariano M, Renga G, Stincardini C, Goldstein AL, Garaci E, Romani L.

Front Oncol. 2019 Sep 6;9:873. doi: 10.3389/fonc.2019.00873. eCollection 2019. Review.

5.

Mass Drug Administration for Scabies - 2 Years of Follow-up.

Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, Tuicakau M, Koroi A, Andrews RM, Kaldor JM, Steer AC.

N Engl J Med. 2019 Jul 11;381(2):186-187. doi: 10.1056/NEJMc1808439. Epub 2019 Jun 26. No abstract available.

PMID:
31242358
6.

A systems genomics approach identifies SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis.

Jaeger M, Pinelli M, Borghi M, Constantini C, Dindo M, van Emst L, Puccetti M, Pariano M, Ricaño-Ponce I, Büll C, Gresnigt MS, Wang X, Gutierrez Achury J, Jacobs CWM, Xu N, Oosting M, Arts P, Joosten LAB, van de Veerdonk FL, Veltman JA, Ten Oever J, Kullberg BJ, Feng M, Adema GJ, Wijmenga C, Kumar V, Sobel J, Gilissen C, Romani L, Netea MG.

Sci Transl Med. 2019 Jun 12;11(496). pii: eaar3558. doi: 10.1126/scitranslmed.aar3558.

PMID:
31189718
7.

The public health control of scabies: priorities for research and action.

Engelman D, Cantey PT, Marks M, Solomon AW, Chang AY, Chosidow O, Enbiale W, Engels D, Hay RJ, Hendrickx D, Hotez PJ, Kaldor JM, Kama M, Mackenzie CD, McCarthy JS, Martin DL, Mengistu B, Maurer T, Negussu N, Romani L, Sokana O, Whitfeld MJ, Fuller LC, Steer AC.

Lancet. 2019 Jul 6;394(10192):81-92. doi: 10.1016/S0140-6736(19)31136-5. Epub 2019 Jun 6. Review.

PMID:
31178154
8.

Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans.

Napolioni V, Pariano M, Borghi M, Oikonomou V, Galosi C, De Luca A, Stincardini C, Vacca C, Renga G, Lucidi V, Colombo C, Fiscarelli E, Lass-Flörl C, Carotti A, D'Amico L, Majo F, Russo MC, Ellemunter H, Spolzino A, Mosci P, Brancorsini S, Aversa F, Velardi A, Romani L, Costantini C.

Front Immunol. 2019 May 7;10:890. doi: 10.3389/fimmu.2019.00890. eCollection 2019.

9.

Prevalence of scabies and impetigo three years after mass drug administration with ivermectin and azithromycin.

Marks M, Romani L, Sokana O, Neko L, Harrington R, Nasi T, Wand H, Whitfeld MJ, Engelman D, Solomon AW, Kaldor JM, Steer AC.

Clin Infect Dis. 2019 May 25. pii: ciz444. doi: 10.1093/cid/ciz444. [Epub ahead of print]

10.

Genistein antagonizes gliadin-induced CFTR malfunction in models of celiac disease.

Esposito S, Villella VR, Ferrari E, Monzani R, Tosco A, Rossin F, D'Eletto M, Castaldo A, Luciani A, Silano M, Bona G, Marseglia GL, Romani L, Piacentini M, Raia V, Kroemer G, Maiuri L.

Aging (Albany NY). 2019 Apr 12;11(7):2003-2019. doi: 10.18632/aging.101888.

11.

Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial.

Romani L, Marks M, Sokana O, Nasi T, Kamoriki B, Cordell B, Wand H, Whitfeld MJ, Engelman D, Solomon AW, Kaldor JM, Steer AC.

Lancet Infect Dis. 2019 May;19(5):510-518. doi: 10.1016/S1473-3099(18)30790-4. Epub 2019 Apr 4.

12.

Autophagy suppresses the pathogenic immune response to dietary antigens in cystic fibrosis.

Villella VR, Esposito S, Ferrari E, Monzani R, Tosco A, Rossin F, Castaldo A, Silano M, Marseglia GL, Romani L, Barlev NA, Piacentini M, Raia V, Kroemer G, Maiuri L.

Cell Death Dis. 2019 Mar 15;10(4):258. doi: 10.1038/s41419-019-1500-x.

13.

Exploration of a simplified clinical examination for scabies to support public health decision-making.

Marks M, Engelman D, Romani L, Mason D, Sokana O, Kama M, Whitfeld M, Steer AC, Kaldor J.

PLoS Negl Trop Dis. 2018 Dec 27;12(12):e0006996. doi: 10.1371/journal.pntd.0006996. eCollection 2018 Dec.

14.

Mast Cells Respond to Candida albicans Infections and Modulate Macrophages Phagocytosis of the Fungus.

De Zuani M, Paolicelli G, Zelante T, Renga G, Romani L, Arzese A, Pucillo CEM, Frossi B.

Front Immunol. 2018 Nov 30;9:2829. doi: 10.3389/fimmu.2018.02829. eCollection 2018.

15.

Challenging diagnosis of congenital malaria in non-endemic areas.

Romani L, Pane S, Severini C, Menegon M, Foglietta G, Bernardi S, Tchidjou HK, Onetti Muda A, Palma P, Putignani L.

Malar J. 2018 Dec 14;17(1):470. doi: 10.1186/s12936-018-2614-9.

16.

Biochemical Characterization of Aspergillus fumigatus AroH, a Putative Aromatic Amino Acid Aminotransferase.

Dindo M, Costanzi E, Pieroni M, Costantini C, Annunziato G, Bruno A, Keller NP, Romani L, Zelante T, Cellini B.

Front Mol Biosci. 2018 Nov 28;5:104. doi: 10.3389/fmolb.2018.00104. eCollection 2018.

17.

IL-9 Integrates the Host-Candida Cross-Talk in Vulvovaginal Candidiasis to Balance Inflammation and Tolerance.

Renga G, Borghi M, Oikonomou V, Mosci P, Bartoli A, Renauld JC, Romani L, Costantini C.

Front Immunol. 2018 Nov 20;9:2702. doi: 10.3389/fimmu.2018.02702. eCollection 2018.

18.

The Mast Cell-Aryl Hydrocarbon Receptor Interplay at the Host-Microbe Interface.

Costantini C, Renga G, Oikonomou V, Paolicelli G, Borghi M, Pariano M, De Luca A, Puccetti M, Stincardini C, Mosci P, Bartoli A, Zelante T, Romani L.

Mediators Inflamm. 2018 Oct 28;2018:7396136. doi: 10.1155/2018/7396136. eCollection 2018. Review.

19.

A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease.

Villella VR, Venerando A, Cozza G, Esposito S, Ferrari E, Monzani R, Spinella MC, Oikonomou V, Renga G, Tosco A, Rossin F, Guido S, Silano M, Garaci E, Chao YK, Grimm C, Luciani A, Romani L, Piacentini M, Raia V, Kroemer G, Maiuri L.

EMBO J. 2019 Jan 15;38(2). pii: e100101. doi: 10.15252/embj.2018100101. Epub 2018 Nov 29.

20.

Role of IL-17RA in the proliferative priming of hepatocytes in liver regeneration.

Piobbico D, Bartoli D, Pieroni S, De Luca A, Castelli M, Romani L, Servillo G, Della-Fazia MA.

Cell Cycle. 2018;17(21-22):2423-2435. doi: 10.1080/15384101.2018.1542893. Epub 2018 Nov 11.

21.

Intravenous immunoglobulin protects from experimental allergic bronchopulmonary aspergillosis via a sialylation-dependent mechanism.

Bozza S, Käsermann F, Kaveri SV, Romani L, Bayry J.

Eur J Immunol. 2019 Jan;49(1):195-198. doi: 10.1002/eji.201847774. Epub 2018 Oct 29.

PMID:
30267564
22.

Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trial.

Romani L, Marks M, Sokana O, Nasi T, Kamoriki B, Wand H, Whitfeld MJ, Engelman D, Solomon AW, Steer AC, Kaldor JM.

Lancet Glob Health. 2018 Oct;6(10):e1132-e1138. doi: 10.1016/S2214-109X(18)30397-8. Erratum in: Lancet Glob Health. 2019 Feb;7(2):e190.

23.

A biological model of scabies infection dynamics and treatment informs mass drug administration strategies to increase the likelihood of elimination.

Lydeamore MJ, Campbell PT, Regan DG, Tong SYC, Andrews RM, Steer AC, Romani L, Kaldor JM, McVernon J, McCaw JM.

Math Biosci. 2019 Mar;309:163-173. doi: 10.1016/j.mbs.2018.08.007. Epub 2018 Aug 24.

PMID:
30149021
24.

Cellular proteostasis: a new twist in the action of thymosin α1.

Stincardini C, Renga G, Villella V, Pariano M, Oikonomou V, Borghi M, Bellet MM, Sforna L, Costantini C, Goldstein AL, Garaci E, Romani L.

Expert Opin Biol Ther. 2018 Jul;18(sup1):43-48. doi: 10.1080/14712598.2018.1484103. Review.

PMID:
30063867
25.

Thymosin β4 limits inflammation through autophagy.

Renga G, Oikonomou V, Stincardini C, Pariano M, Borghi M, Costantini C, Bartoli A, Garaci E, Goldstein AL, Romani L.

Expert Opin Biol Ther. 2018 Jul;18(sup1):171-175. doi: 10.1080/14712598.2018.1473854. Review.

PMID:
30063848
26.

Randomized Trial of Community Treatment With Azithromycin and Ivermectin Mass Drug Administration for Control of Scabies and Impetigo.

Marks M, Toloka H, Baker C, Kositz C, Asugeni J, Puiahi E, Asugeni R, Azzopardi K, Diau J, Kaldor JM, Romani L, Redman-MacLaren M, MacLaren D, Solomon AW, Mabey DCW, Steer AC.

Clin Infect Dis. 2019 Mar 5;68(6):927-933. doi: 10.1093/cid/ciy574.

27.

Reply to 'F508del-CFTR is not corrected by thymosin α1'.

Romani L, Stincardini C, Giovagnoli S, Paci M, Villella VR, Sforna L, Renga G, Bellet MM, Costantini C, Puccetti P, Kroemer G, Maiuri L, Pessia M, Goldstein A, Garaci E.

Nat Med. 2018 Jul;24(7):891-893. doi: 10.1038/s41591-018-0080-0. No abstract available.

PMID:
29942090
28.

Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis.

Romani L, Oikonomou V, Moretti S, Iannitti RG, D'Adamo MC, Villella VR, Pariano M, Sforna L, Borghi M, Bellet MM, Fallarino F, Pallotta MT, Servillo G, Ferrari E, Puccetti P, Kroemer G, Pessia M, Maiuri L, Goldstein AL, Garaci E.

Nat Med. 2018 Sep;24(9):1482. doi: 10.1038/s41591-018-0099-2.

PMID:
29934535
29.

Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis.

Romani L, Oikonomou V, Moretti S, Iannitti RG, D'Adamo MC, Villella VR, Pariano M, Sforna L, Borghi M, Bellet MM, Fallarino F, Pallotta MT, Servillo G, Ferrari E, Puccetti P, Kroemer G, Pessia M, Maiuri L, Goldstein AL, Garaci E.

Nat Med. 2018 Sep;24(9):1481. doi: 10.1038/s41591-018-0100-0.

PMID:
29934534
30.

IL-9 and Mast Cells Are Key Players of Candida albicans Commensalism and Pathogenesis in the Gut.

Renga G, Moretti S, Oikonomou V, Borghi M, Zelante T, Paolicelli G, Costantini C, De Zuani M, Villella VR, Raia V, Del Sordo R, Bartoli A, Baldoni M, Renauld JC, Sidoni A, Garaci E, Maiuri L, Pucillo C, Romani L.

Cell Rep. 2018 May 8;23(6):1767-1778. doi: 10.1016/j.celrep.2018.04.034.

31.

Physicochemical characterization, the Hirshfeld surface, and biological evaluation of two meloxicam compounding pharmacy samples.

Romani LFA, Yoshida MI, Gomes ECL, Machado RR, Rodrigues FF, Coelho MM, Oliveira MA, Freitas-Marques MB, San Gil RAS, Mussel WN.

J Pharm Anal. 2018 Apr;8(2):103-108. doi: 10.1016/j.jpha.2017.12.006. Epub 2017 Dec 19.

32.

Development of Novel Indole-3-Aldehyde-Loaded Gastro-Resistant Spray-Dried Microparticles for Postbiotic Small Intestine Local Delivery.

Puccetti M, Giovagnoli S, Zelante T, Romani L, Ricci M.

J Pharm Sci. 2018 Sep;107(9):2341-2353. doi: 10.1016/j.xphs.2018.04.023. Epub 2018 Apr 30.

PMID:
29715478
33.

Autophagy and LAP in the Fight against Fungal Infections: Regulation and Therapeutics.

Oikonomou V, Renga G, De Luca A, Borghi M, Pariano M, Puccetti M, Paolicelli G, Stincardini C, Costantini C, Bartoli A, Zelante T, Romani L.

Mediators Inflamm. 2018 Mar 6;2018:6195958. doi: 10.1155/2018/6195958. eCollection 2018. Review.

34.

Towards Targeting the Aryl Hydrocarbon Receptor in Cystic Fibrosis.

Puccetti M, Paolicelli G, Oikonomou V, De Luca A, Renga G, Borghi M, Pariano M, Stincardini C, Scaringi L, Giovagnoli S, Ricci M, Romani L, Zelante T.

Mediators Inflamm. 2018 Feb 18;2018:1601486. doi: 10.1155/2018/1601486. eCollection 2018. Review.

35.

The Potential Role of Toll-Like Receptor 4 in Mediating Dopaminergic Cell Loss and Alpha-Synuclein Expression in the Acute MPTP Mouse Model of Parkinson's Disease.

Mariucci G, Pagiotti R, Galli F, Romani L, Conte C.

J Mol Neurosci. 2018 Apr;64(4):611-618. doi: 10.1007/s12031-018-1057-7. Epub 2018 Mar 27.

PMID:
29589201
36.

Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes.

Orabona C, Mondanelli G, Pallotta MT, Carvalho A, Albini E, Fallarino F, Vacca C, Volpi C, Belladonna ML, Berioli MG, Ceccarini G, Esposito SM, Scattoni R, Verrotti A, Ferretti A, De Giorgi G, Toni S, Cappa M, Matteoli MC, Bianchi R, Matino D, Iacono A, Puccetti M, Cunha C, Bicciato S, Antognelli C, Talesa VN, Chatenoud L, Fuchs D, Pilotte L, Van den Eynde B, Lemos MC, Romani L, Puccetti P, Grohmann U.

JCI Insight. 2018 Mar 22;3(6). pii: 96244. doi: 10.1172/jci.insight.96244.

37.

The contribution of mast cells to bacterial and fungal infection immunity.

Piliponsky AM, Romani L.

Immunol Rev. 2018 Mar;282(1):188-197. doi: 10.1111/imr.12623. Review.

38.

A Multifaceted Role of Tryptophan Metabolism and Indoleamine 2,3-Dioxygenase Activity in Aspergillus fumigatus-Host Interactions.

Choera T, Zelante T, Romani L, Keller NP.

Front Immunol. 2018 Jan 22;8:1996. doi: 10.3389/fimmu.2017.01996. eCollection 2017. Review.

39.

Disease Tolerance Mediated by Phosphorylated Indoleamine-2,3 Dioxygenase Confers Resistance to a Primary Fungal Pathogen.

de Araújo EF, Loures FV, Feriotti C, Costa T, Vacca C, Puccetti P, Romani L, Calich VLG.

Front Immunol. 2017 Nov 13;8:1522. doi: 10.3389/fimmu.2017.01522. eCollection 2017.

40.

Aspergillus fumigatus morphology and dynamic host interactions.

van de Veerdonk FL, Gresnigt MS, Romani L, Netea MG, Latgé JP.

Nat Rev Microbiol. 2017 Nov;15(11):661-674. doi: 10.1038/nrmicro.2017.90. Epub 2017 Sep 18. Review.

PMID:
28919635
41.

The Epidemiology of Scabies and Impetigo in Relation to Demographic and Residential Characteristics: Baseline Findings from the Skin Health Intervention Fiji Trial.

Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, Tuicakau M, Koroi A, Ritova R, Andrews R, Kaldor JM, Steer AC.

Am J Trop Med Hyg. 2017 Sep;97(3):845-850. doi: 10.4269/ajtmh.16-0753. Epub 2017 Jul 19.

42.

Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis.

Romani L, Oikonomou V, Moretti S, Iannitti RG, D'Adamo MC, Villella VR, Pariano M, Sforna L, Borghi M, Bellet MM, Fallarino F, Pallotta MT, Servillo G, Ferrari E, Puccetti P, Kroemer G, Pessia M, Maiuri L, Goldstein AL, Garaci E.

Nat Med. 2017 May;23(5):590-600. doi: 10.1038/nm.4305. Epub 2017 Apr 10. Erratum in: Nat Med. 2018 Sep;24(9):1481. Nat Med. 2018 Sep;24(9):1482.

43.

Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use.

Aversa F, Busca A, Candoni A, Cesaro S, Girmenia C, Luppi M, Nosari AM, Pagano L, Romani L, Rossi G, Venditti A, Novelli A.

J Chemother. 2017 Jun;29(3):131-143. doi: 10.1080/1120009X.2017.1306183. Epub 2017 Mar 24. Review.

PMID:
28335692
44.

Role of TLR1, TLR2 and TLR6 in the modulation of intestinal inflammation and Candida albicans elimination.

Choteau L, Vancraeyneste H, Le Roy D, Dubuquoy L, Romani L, Jouault T, Poulain D, Sendid B, Calandra T, Roger T, Jawhara S.

Gut Pathog. 2017 Feb 15;9:9. doi: 10.1186/s13099-017-0158-0. eCollection 2017.

45.

A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis.

Moretti S, Renga G, Oikonomou V, Galosi C, Pariano M, Iannitti RG, Borghi M, Puccetti M, De Zuani M, Pucillo CE, Paolicelli G, Zelante T, Renauld JC, Bereshchenko O, Sportoletti P, Lucidi V, Russo MC, Colombo C, Fiscarelli E, Lass-Flörl C, Majo F, Ricciotti G, Ellemunter H, Ratclif L, Talesa VN, Napolioni V, Romani L.

Nat Commun. 2017 Jan 16;8:14017. doi: 10.1038/ncomms14017.

46.

Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis.

Vallerini D, Forghieri F, Lagreca I, Riva G, Barozzi P, Quadrelli C, Morselli M, Bresciani P, Cuoghi A, Coluccio V, Maccaferri M, Paolini A, Colaci E, Marasca R, Narni F, Cellini M, Beauvais A, Latgè JP, Romani L, Iughetti L, Comoli P, Campioli D, Trenti T, Luppi M, Potenza L.

J Infect. 2017 Mar;74(3):314-318. doi: 10.1016/j.jinf.2016.12.008. Epub 2016 Dec 23. No abstract available.

PMID:
28017824
47.

Noncanonical Fungal Autophagy Inhibits Inflammation in Response to IFN-γ via DAPK1.

Oikonomou V, Moretti S, Renga G, Galosi C, Borghi M, Pariano M, Puccetti M, Palmerini CA, Amico L, Carotti A, Prezioso L, Spolzino A, Finocchi A, Rossi P, Velardi A, Aversa F, Napolioni V, Romani L.

Cell Host Microbe. 2016 Dec 14;20(6):744-757. doi: 10.1016/j.chom.2016.10.012. Epub 2016 Nov 23.

48.

Food security and the nutritional status of children in foster care: new horizons in the protection of a fragile population.

Ferrara P, Scancarello M, Khazrai YM, Romani L, Cutrona C, DE Gara L, Bona G.

Minerva Pediatr. 2016 Oct 12. [Epub ahead of print]

PMID:
27733749
49.

The Prevalence of Scabies and Impetigo in the Solomon Islands: A Population-Based Survey.

Mason DS, Marks M, Sokana O, Solomon AW, Mabey DC, Romani L, Kaldor J, Steer AC, Engelman D.

PLoS Negl Trop Dis. 2016 Jun 27;10(6):e0004803. doi: 10.1371/journal.pntd.0004803. eCollection 2016 Jun.

50.

Mass Drug Administration for Scabies Control.

Steer AC, Romani L, Kaldor JM.

N Engl J Med. 2016 Apr 28;374(17):1690. doi: 10.1056/NEJMc1600495. No abstract available.

PMID:
27119244

Supplemental Content

Loading ...
Support Center